Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
about
Increased cytochrome P4502E1 expression and altered hydroxyeicosatetraenoic acid formation mediate diabetic vascular dysfunction: rescue by guanylyl-cyclase activation.Identification of free nitric oxide radicals in rat bone marrow: implications for progenitor cell mobilization in hypertensionThe effects of 17-methoxyl-7-hydroxy-benzene-furanchalcone on the pressure overload-induced progression of cardiac hypertrophy to cardiac failure.Therapeutic effect of enhancing endothelial nitric oxide synthase (eNOS) expression and preventing eNOS uncoupling.The nitric oxide donor pentaerythritol tetranitrate reduces platelet activation in congestive heart failure.Aquaporin-1 Deficiency Protects Against Myocardial Infarction by Reducing Both Edema and Apoptosis in MiceExercise training improves vascular mitochondrial function.Nitrite therapy improves left ventricular function during heart failure via restoration of nitric oxide-mediated cytoprotective signaling.Pathological ventricular remodeling: therapies: part 2 of 2.Potential novel pharmacological therapies for myocardial remodelling.Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation.Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction.Modulating the nitric oxide - cyclic GMP pathway in the pressure-overloaded left ventricle and group II pulmonary hypertension.Conflicting effects of nitric oxide and oxidative stress in chronic heart failure: potential therapeutic strategies.Modulating endothelial nitric oxide synthase: a new cardiovascular therapeutic strategy.Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.Non-cardiomyocyte microRNAs in heart failure.Angiogenesis in the infarcted myocardium.Endothelial progenitor cells: from senescence to rejuvenation.Autonomic Dysregulation as a Therapeutic Target for Acute HF.Targeting vascular (endothelial) dysfunction.Contemporary Approaches to Modulating the Nitric Oxide-cGMP Pathway in Cardiovascular Disease.MiR-216a: a link between endothelial dysfunction and autophagy.Inhibition of TGF-β1 by eNOS gene transfer provides cardiac protection after myocardial infarction.Aminoethyl nitrate--the novel super nitrate?Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.Inhibition of platelet activation in rats with severe congestive heart failure by a novel endothelial nitric oxide synthase transcription enhancer.The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.Mechanistic studies of AVE3085 against homocysteine in endothelial protection.
P2860
Q34024378-B3048648-8C86-4E2E-8FEC-4EAD1595C7B3Q34647889-46AC6B36-71FD-487F-88EB-C3762B775710Q35119055-607D61D7-A9DF-4683-888B-224B100E90C7Q35216447-05474C8F-5692-42AE-AE22-DCE3AFF988ACQ35619474-B3367454-EC95-4489-9ABE-270443FE3DB0Q36035521-D8FFB61A-2EA5-4132-AD11-8674F763688EQ36902422-6A4A6878-BC78-4F4F-B1EC-14D44AD9A6CFQ37090170-B82B725B-4896-4FFE-BFD5-1E6840F23FC3Q37312758-9F9C5759-D4DC-49E4-95DA-F61B32075CCBQ37329709-AAA0ED64-AF6F-40F7-91F2-F02E25E49F29Q37775559-C2190E3C-9831-400C-A40F-111D2F41AA60Q37780204-5DF06FEF-5549-4F87-ACF9-1BD6B567BDF5Q37799652-E999B64F-302A-435F-8F34-F5BEA44CF5E9Q37835753-F76F9D53-22F1-4387-BF00-31DC86BBA122Q37881801-29BE9A6A-2FA1-4A8F-8934-55EC22E1EC8AQ37968218-6DA91625-B79A-4F1F-A0D5-13F06F8309CDQ37969738-FBC9BAD3-4115-4699-B695-A03BE234B4CCQ38032602-7DB04AAC-4D93-48CA-BD47-682052E182E2Q38248787-F13775F6-1178-4784-BFD8-20309720AD0BQ38573100-F86BBA87-7A39-4EBB-9A27-93AA696FB46FQ38836199-7F44E7BD-94B0-4254-9816-16FD8D2A7690Q39209626-439BE818-17DB-4D67-8722-880914927CF7Q40138320-47AC0EF3-6D3A-4D82-9D77-4BC906FC0F02Q41169833-5A80ECE3-AF2A-4BF5-B20D-0F9C7E11A329Q42268160-C2F069CF-2B58-480A-BF43-4C21931A7C2AQ44889332-8BFC9D9B-CC02-4550-815E-927CB05F2317Q46133367-C1EC7EB5-A0B5-42B9-A7D1-9FE572102C93Q47667272-F23316FD-5446-4B1C-8630-CB63066C15E5Q48023486-885CA1EF-DAB1-463C-AF7E-25A9704B5CAD
P2860
Improvement in left ventricular remodeling by the endothelial nitric oxide synthase enhancer AVE9488 after experimental myocardial infarction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Improvement in left ventricula ...... imental myocardial infarction.
@en
Improvement in left ventricula ...... imental myocardial infarction.
@nl
type
label
Improvement in left ventricula ...... imental myocardial infarction.
@en
Improvement in left ventricula ...... imental myocardial infarction.
@nl
prefLabel
Improvement in left ventricula ...... imental myocardial infarction.
@en
Improvement in left ventricula ...... imental myocardial infarction.
@nl
P2093
P1433
P1476
Improvement in left ventricula ...... imental myocardial infarction.
@en
P2093
Daniela Fraccarollo
Dimitrios Tsikas
Georg Ertl
Hartmut Ruetten
Johann Bauersachs
Julian D Widder
Michael Hoffmann
Paolo Galuppo
P304
P356
10.1161/CIRCULATIONAHA.107.717702
P407
P50
P577
2008-08-04T00:00:00Z